The promises and pitfalls of RNA-interference-based therapeutics
about
Role of exosomes/microvesicles in the nervous system and use in emerging therapiesMicroRNA 329 suppresses angiogenesis by targeting CD146Secretory mechanisms and intercellular transfer of microRNAs in living cellsMicroneedles As a Delivery System for Gene TherapyCell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidMultifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule deliveryMicroRNA in carcinogenesis & cancer diagnostics: a new paradigmNanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophyGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceThe emergence of lncRNAs in cancer biologyThe role of DNA methylation in aging, rejuvenation, and age-related diseaseCurrent status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinomaMultiple exportins influence thyroid hormone receptor localizationHymyc1 downregulation promotes stem cell proliferation in Hydra vulgarisHydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse BrainAbasic pivot substitution harnesses target specificity of RNA interferenceThe role of RNAi and microRNAs in animal virus replication and antiviral immunityNucleation, propagation and cleavage of target RNAs in Ago silencing complexes.Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesRNA-targeted Therapeutics for ALSCurrent Therapeutic Advances Targeting EGFR and EGFRvIII in GlioblastomaTherapeutic genome editing: prospects and challengesDirect translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticlesReconsideration of in-silico siRNA design based on feature selection: a cross-platform data integration perspectiveEGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interferencesiRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in ratsHuman RGM249-derived small RNAs potentially regulate tumor malignancyExpression of multiple artificial microRNAs from a chicken miRNA126-based lentiviral vectorEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesEbola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Gene silencing: a therapeutic approach to combat influenza virus infections.Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1.Regeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNAIntracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liverSniffing for gene-silencing efficiency of siRNAs in HeLa cells in comparison with that in HEK293T cells: correlation between knockdown efficiency and sustainability of sirnas revealed by FRET-based probingIn silico target-specific siRNA design based on domain transfer in heterogeneous data.siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
P2860
Q21129255-44BB7D18-4479-45A7-8BD8-927E1900EB1BQ24310981-23F0EA99-AB21-4D4B-AB3A-BDFFB6468642Q24603413-BF744C24-17C5-4CCD-A0B4-8F3BE22DE502Q26746026-DD712AED-0E9A-44CF-BAF6-5B82B1DB522AQ26774462-835888B4-D3FC-4232-B8F9-E5413B051D1BQ26830434-08B728F2-F815-42D4-85CB-3032F50337C1Q26863669-EAE59219-3C66-4969-BB3D-95887D9BF30CQ26992271-184EFB3C-0EA0-43D5-8CEF-7B8CE292D46BQ27022347-66B57BA7-71AE-4CE2-8F75-46A67E70AC4CQ27024237-AE5354E1-C130-40CE-A706-9210B6116B99Q27025194-59D9E31C-201E-43F0-A582-C0ED22FC0F02Q27026846-54A58BF7-159B-409F-AA5E-FD7DA93D937EQ27308843-14579B5A-A24C-4E89-AD34-D0F6B0DE53C6Q27309314-FD634F77-5729-4C53-8408-B7EFFF483321Q27317421-3C97B201-605C-409A-A88C-3BD64CB49E0FQ27339381-94BEE75E-E3D3-44C3-B438-C644E10311C7Q27490179-11B26626-9858-483B-AD69-B6A095212587Q27657724-FB768A97-5059-47C0-9242-01843136AA78Q27692125-6F499175-F086-4952-9392-059B9456F2FEQ28067499-48502EAE-FFAC-4DEF-84B2-5F650AFE9301Q28083290-044A003F-6733-4810-9DD6-A7FE9BBE7111Q28087306-91F7C9AA-B079-405A-B9CE-631C05AB7650Q28087380-815460C1-AE26-4271-9840-DDC13B2896F5Q28477376-EAF34706-A225-4EE3-B846-A0F3EEB2E097Q28483920-F3D18439-781B-42EB-8ED6-B37CC477F71CQ28486127-1A22B6FC-0101-4F6D-A0C9-B5D266CEA995Q28582042-74F69F19-4EA9-46DC-8AC1-1200603069BDQ28681257-BE544CFC-3C1A-48A8-BDB9-27E66D2A3FB7Q28742456-4680F008-4702-48B7-86D6-088203257BADQ29615957-C31F9578-6D75-4750-B44B-BE1CDCC9CC2EQ30251949-7F522DFA-959B-4FD0-9EA4-C568CCA4DBB3Q30370880-6EF4F52E-567B-4893-BE31-D4A712883040Q30374057-BE70563D-CCDD-4AA8-A7CB-1E35A19A1BA4Q30404683-7CC383F6-EBD0-4F22-B3AD-14213D45BBFDQ30429653-3770C1E1-8EB4-42AF-87BC-2AC9B60939C1Q30434397-BBE3DECE-254A-4217-A2BE-0E7D915DD0C1Q30434933-59A23D1B-766C-4DEF-9077-62C0E8A7C372Q30538460-2DE766EB-8A8A-41E1-84C5-226131B06155Q30584270-FB451250-C1C6-4749-A73E-5E88EDD955BEQ30931909-E8EDAB82-C27C-45BE-9ADD-1A984E8C8F40
P2860
The promises and pitfalls of RNA-interference-based therapeutics
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The promises and pitfalls of RNA-interference-based therapeutics
@ast
The promises and pitfalls of RNA-interference-based therapeutics
@en
The promises and pitfalls of RNA-interference-based therapeutics
@nl
type
label
The promises and pitfalls of RNA-interference-based therapeutics
@ast
The promises and pitfalls of RNA-interference-based therapeutics
@en
The promises and pitfalls of RNA-interference-based therapeutics
@nl
prefLabel
The promises and pitfalls of RNA-interference-based therapeutics
@ast
The promises and pitfalls of RNA-interference-based therapeutics
@en
The promises and pitfalls of RNA-interference-based therapeutics
@nl
P2860
P3181
P356
P1433
P1476
The promises and pitfalls of RNA-interference-based therapeutics
@en
P2093
Daniela Castanotto
John J Rossi
P2860
P2888
P304
P3181
P356
10.1038/NATURE07758
P407
P577
2009-01-22T00:00:00Z
P5875
P6179
1021098775